✦ LIBER ✦

Therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea

✍ Scribed by Tr�mper, Lorenz H. ;Ho, Anthony D. ;Hunstein, Werner ;Lelie, Hans ;Goudsmit, Rob

Publisher: Springer-Verlag
Year: 1989
Weight: 257 KB
Volume: 58
Category: Article
ISSN: 1432-0584
DOI: 10.1007/bf00320655

No coin nor oath required. For personal study only.

✦ Synopsis

Treatment of the myeloid blast phase of chronic granulocytic leukemia is still a major problem in clinical hematology. Alternate-day plicamycin and hydroxyurea treatment was reported to induce remissions in the majority of patients with myeloid blast phase by Koller and Miller in 1986 Subsequently we treated eight patients according to this regimen. Complete remissions could not be achieved and no prolongation of median survival was observed. In two patients treatment had to be discontinued due to severe toxicity.

📜 SIMILAR VOLUMES

Therapy of refractory/relapsed acute mye

Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin

✍ Jonathan H. Marsh; Willi Kreis; Barbara Barile; Silvia Akerman; Philip Schulman; 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 428 KB

Failure of mithramycin to control the my

Failure of mithramycin to control the myeloid blast phase of chronic granulocytic leukemia: A report on nine patients and review of the literature

✍ P. R. E. Johnson; Dr J. A. Liu Yin; M. N. Narayanan; C. G. Geary; E. M. Love; K. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

After reports of the successful use of mithramycin and hydroxyurea in the myeloid blast phase of chronic granulocytic leukemia, we treated nine patients according to the protocol devised by . There were no complete responses, but one patient had a partial response with a transient return to the chro

Randomized study on the treatment of chr

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alpha

✍ Hehlmann, R. ;Anger, B. ;Messerer, D. ;Zankovich, R. ;Bergmann, L. ;Kolb, H. J. 📂 Article 📅 1988 🏛 Springer-Verlag ⚖ 453 KB

t(3;21)(q26;q22) in myeloid leukemia : A

t(3;21)(q26;q22) in myeloid leukemia : An aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy

✍ C. Cameron Yin; Jorge Cortes; Bedia Barkoh; Kimberly Hayes; Hagop Kantarjian; Da 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Phase I–II trial of VP-16 in the treatme

Phase I–II trial of VP-16 in the treatment of acute nonlymphocytic leukemia and blast crisis of chronic granulocytic leukemia

✍ Mailliard, James A. ;Letendre, Louis ;Dalton, Robert J. ;Levitt, Ralph ;Gerstner 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB

VP-16 was used to treat newly diagnosed elderly ( 2 6 5 yr) patients with acute nonlymphocytic leukemia (ANLL) and patients with blast crisis of chronic granulocytic leukemia (BI-CGL). Our pilot study indicated that VP-I6 160 mg/m2 intravenously daily for 5 days was well tolerated and suggested a di

A study of the myeloid differentiation a

A study of the myeloid differentiation antigens of the peripheral blood neutrophil granulocytes in the different evolutive phases of chronic myeloid leukemia

✍ M. Rozman; F. Cervantes; C. Rozman 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 383 KB